114 related articles for article (PubMed ID: 34049822)
1. Hyperglycemia as a risk factor in pancreatic cancer: A nested case-control study using prediagnostic blood glucose levels.
Jacobson S; Dahlqvist P; Johansson M; Svensson J; Billing O; Sund M; Franklin O
Pancreatology; 2021 May; ():. PubMed ID: 34049822
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer.
Wolpin BM; Bao Y; Qian ZR; Wu C; Kraft P; Ogino S; Stampfer MJ; Sato K; Ma J; Buring JE; Sesso HD; Lee IM; Gaziano JM; McTiernan A; Phillips LS; Cochrane BB; Pollak MN; Manson JE; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2013 Jul; 105(14):1027-35. PubMed ID: 23847240
[TBL] [Abstract][Full Text] [Related]
3. Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis.
Sharma A; Smyrk TC; Levy MJ; Topazian MA; Chari ST
Gastroenterology; 2018 Aug; 155(2):490-500.e2. PubMed ID: 29723506
[TBL] [Abstract][Full Text] [Related]
4. Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence.
Keum N; Ha KH; Bao Y; Chung MJ; Kim HC; Giovannucci EL
Cancer Causes Control; 2018 Jan; 29(1):135-142. PubMed ID: 29197995
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women.
Michaud DS; Wolpin B; Giovannucci E; Liu S; Cochrane B; Manson JE; Pollak MN; Ma J; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2101-9. PubMed ID: 17905943
[TBL] [Abstract][Full Text] [Related]
6. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers.
Stolzenberg-Solomon RZ; Graubard BI; Chari S; Limburg P; Taylor PR; Virtamo J; Albanes D
JAMA; 2005 Dec; 294(22):2872-8. PubMed ID: 16352795
[TBL] [Abstract][Full Text] [Related]
7. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
[TBL] [Abstract][Full Text] [Related]
8. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
9. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
Li D; Morris JS; Liu J; Hassan MM; Day RS; Bondy ML; Abbruzzese JL
JAMA; 2009 Jun; 301(24):2553-62. PubMed ID: 19549972
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.
Bao Y; Giovannucci EL; Kraft P; Stampfer MJ; Ogino S; Ma J; Buring JE; Sesso HD; Lee IM; Gaziano JM; Rifai N; Pollak MN; Cochrane BB; Kaklamani V; Lin JH; Manson JE; Fuchs CS; Wolpin BM
J Natl Cancer Inst; 2013 Jan; 105(2):95-103. PubMed ID: 23243202
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia predicts adverse prognosis in advanced pancreatic cancer patients.
Zhu X; Xu H; Xiao Z; Liu H; Ni Q; Yu X; Luo G
Endocrine; 2023 Feb; 79(2):296-303. PubMed ID: 36609907
[TBL] [Abstract][Full Text] [Related]
12. Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort.
Katagiri R; Goto A; Nakagawa T; Nishiumi S; Kobayashi T; Hidaka A; Budhathoki S; Yamaji T; Sawada N; Shimazu T; Inoue M; Iwasaki M; Yoshida M; Tsugane S
Gastroenterology; 2018 Nov; 155(5):1474-1482.e1. PubMed ID: 30076838
[TBL] [Abstract][Full Text] [Related]
13. Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry-based metabolomics: A case-control study nested in the Northern Sweden Health and Disease Study.
Östman JR; Pinto RC; Ebbels TMD; Thysell E; Hallmans G; Moazzami AA
Int J Cancer; 2022 Dec; 151(12):2115-2127. PubMed ID: 35866293
[TBL] [Abstract][Full Text] [Related]
14. Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis.
Liao WC; Tu YK; Wu MS; Lin JT; Wang HP; Chien KL
BMJ; 2015 Jan; 350():g7371. PubMed ID: 25556126
[TBL] [Abstract][Full Text] [Related]
15. Fasting serum glucose level and cancer risk in Korean men and women.
Jee SH; Ohrr H; Sull JW; Yun JE; Ji M; Samet JM
JAMA; 2005 Jan; 293(2):194-202. PubMed ID: 15644546
[TBL] [Abstract][Full Text] [Related]
16. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.
Sarwar N; Aspelund T; Eiriksdottir G; Gobin R; Seshasai SR; Forouhi NG; Sigurdsson G; Danesh J; Gudnason V
PLoS Med; 2010 May; 7(5):e1000278. PubMed ID: 20520805
[TBL] [Abstract][Full Text] [Related]
17. Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis.
Wadström K; Jacobsson L; Mohammad AJ; Warrington KJ; Matteson EL; Turesson C
Rheumatology (Oxford); 2020 Nov; 59(11):3229-3236. PubMed ID: 32240313
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men.
Nakanishi N; Nakamura K; Matsuo Y; Suzuki K; Tatara K
Ann Intern Med; 2000 Aug; 133(3):183-91. PubMed ID: 10906832
[TBL] [Abstract][Full Text] [Related]
19. Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
Stolzenberg-Solomon R; Derkach A; Moore S; Weinstein SJ; Albanes D; Sampson J
Gut; 2020 Nov; 69(11):2008-2015. PubMed ID: 32060129
[TBL] [Abstract][Full Text] [Related]
20. Fasting blood glucose and risk of incident pancreatic cancer.
Kim YJ; Oh CM; Park SK; Jung JY; Kim MH; Ha E; Nam DJ; Kim Y; Yang EH; Lee HC; Shin SS; Ryoo JH
PLoS One; 2022; 17(10):e0274195. PubMed ID: 36301855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
